Similar Search Results

Does prospectus AE affect IPO underpricing? : a content analysis of the Chinese stock market

Guo, Haifeng; Wang, Ying; Wang, Bo; Ge, Yuanjing - In: International review of economics & finance : IREF 82 (2022), pp. 1-12

Persistent link: https://www.econbiz.de/10013542825

CEO effects on the IPO market under different policy regimes : evidence from the Chinese SME board

Ge, Yuanjing; Guo, Haifeng; Fung, Hung-gay; Guang, Kuncheng - In: International review of economics & finance : IREF 63 (2019), pp. 163-175

Persistent link: https://www.econbiz.de/10012321935

How did the elimination of the window guidance policy affect IPO performance in China? : a stochastic dominance analysis

Guo, Haifeng; Ge, Yuanjing; Hsu, Chuan-Hao; Fung, Hung-gay - In: Emerging markets, finance & trade : a journal of the … 57 (2021) 3, pp. 824-838

Persistent link: https://www.econbiz.de/10012483258

Duration of IPOs between offering and listing : Cox proportional hazard modelsEvidence for Chinese A-share IPOs

Guo, Haifeng; Brooks, Robert - In: International review of financial analysis 18 (2009) 5, pp. 239-249

This paper estimates the duration from offering to listing of Chinese A-share IPOs issued from 1994 to 2005. We firstly compare the effects of the two issuing systems on the length of this duration and find that the waiting time to listing has been shortened greatly after the Approval System is...

Persistent link: https://www.econbiz.de/10003936541

Underpricing of Chinese initial public offerings

Guo, Haifeng; Brooks, Robert; Fung, Hung-gay - In: The Chinese economy 44 (2011) 5, pp. 72-85

Persistent link: https://www.econbiz.de/10009314986

Detecting hot and cold cycles using a Markov regime switching model : evidence from the Chinese A-share IPO market

Guo, Haifeng; Brooks, Robert; Shami, Roland G. - In: International review of economics & finance : IREF 19 (2010) 2, pp. 196-210

Persistent link: https://www.econbiz.de/10008669391

Underpricing of Chinese A-share IPOs and short-run underperformance under the approval system from 2001 to 2005

Guo, Haifeng; Brooks, Robert - In: International review of financial analysis 17 (2008) 5, pp. 984-997

Persistent link: https://www.econbiz.de/10003792335

Shadow banking and firm financing in China

Lu, Yunlin; Guo, Haifeng; Kao, Erin H.; Fung, Hung-gay - In: International review of economics & finance : IREF 36 (2015), pp. 40-53

Persistent link: https://www.econbiz.de/10011535637

Research on financing efficiency of China's strategic emerging industries based on super efficiency DEA and tobit model

Chen, Xiangyuan; Wang, Ying - In: International journal of emerging markets 17 (2022) 2, pp. 485-504

Persistent link: https://www.econbiz.de/10012886392

Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non-small cell lung cancer in China

Liu, Huiqin; Wang, Ying; He, Qi - In: Health economics review 12 (2022) 1, pp. 1-10

Objective In frst-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC), the ORIENT-11 study demonstrated a signifcant progression-free survival and overall survival for sintilimab plus chemotherapy in comparison with chemotherapy alone. But the...

Persistent link: https://www.econbiz.de/10013492965